The Shareholders Of Aspen Pharmacare Holdings Ltd

Earnings per share (also called net income per share) is a ratio that measures net income earned per share of stock outstanding, and is the money each share of stock would receive if all of the profits were distributed to the outstanding shares at year end. The higher the EPS, the better the business is as an investment from a shareholders perspective. EPS could be due to an increase in profit or a decrease in the number of shares in issue, which causes the return for each share to be higher. Application: Earnings per Share serve as an indicator of a company s profitability. The EPS increased 325 cents from 773 cents in 2013 to 1098 cents in 2014. The company’s profitability increased by 42% in 2014, which is a great improvement from 2013. Profits increased from R3 514 100 000 in 2013 to R5 005 500 000 in 2014, and this played a big role in causing the EPS to increase by 42%. The shareholders of Aspen Pharmacare Holdings Ltd should be satisfied as the current year (2014) EPS was higher than usual, and a higher earnings per share ratio often makes the stock price of a company rise. Earnings Yield Earnings Yield 2013 = 37.71% Earnings Yield 2014 =37.60% Decreased 0.11% from 37.71% to 37.60% Definition: The Earnings Yield (the reciprocal of the P/E Ratio) can be used to easily compare the earnings of stock or the whole market against bond yields. It is the relationship between the company’s share price and earnings per share. Generally, the Earnings Yields ofShow MoreRelatedAspen Pharmacare Holdings Ltd What s Behind One Of The Jse s Stand Out Shares Over The Past Two Essay1309 Words   |  6 PagesThe Investment Case – Aspen Pharmacare Holdings Ltd What’s behind one of the JSE’s stand-out SHARES over the past two years? Patrick Cairns | 12 January 2011 01:54 Aspen Holdings, Investing 101 ORAPA – Despite the pressures of intense competition and restrictive legislation, the South African pharmaceutical industry finds itself in strong health. Over the past two years, all of the three largest pharmaceutical shares listed on the JSE have been amongst the bourse‘s most robust performers. The SHARERead MoreShare Repurchases and the Protection of13310 Words   |  54 PagesShare repurchases and the protection of shareholders* KATHLEEN VAN DER LINDE** 1 Introduction From a creditor’s perspective there is not much difference between the payment of a dividend in respect of a share and a payment for the acquisition or repurchase of that share. However, from the point of view of the shareholder a dividend is a return on capital while a repurchase is a return of capital to the vendor shareholder. Share repurchases change the structure of the company’s share capitalRead MoreGsk Annual Report 2010135604 Words   |  543 PagesP102–P191 Shareholder information P192–P212 Business review 2010 Performance overview Research and development Pipeline summary Products, competition and intellectual property Regulation Manufacturing and supply World market GSK sales performance Segment reviews Responsible business Financial review 2010 Financial position and resources Financial review 2009 Risk factors Governance and remuneration Our Board Our Corporate Executive Team Governance and policy Dialogue with shareholders Internal